103 related articles for article (PubMed ID: 9459315)
1. The occurrence of subsequent malignancy in patients presenting with deep vein thrombosis: results from a historical cohort study.
Rajan R; Levine M; Gent M; Hirsh J; Geerts W; Skingley P; Julian J
Thromb Haemost; 1998 Jan; 79(1):19-22. PubMed ID: 9459315
[TBL] [Abstract][Full Text] [Related]
2. The clinical course of deep-vein thrombosis. Prospective long-term follow-up of 528 symptomatic patients.
Prandoni P; Villalta S; Bagatella P; Rossi L; Marchiori A; Piccioli A; Bernardi E; Girolami B; Simioni P; Girolami A
Haematologica; 1997; 82(4):423-8. PubMed ID: 9299855
[TBL] [Abstract][Full Text] [Related]
3. Optimal duration of oral anticoagulant therapy: a randomized trial comparing four weeks with three months of warfarin in patients with proximal deep vein thrombosis.
Levine MN; Hirsh J; Gent M; Turpie AG; Weitz J; Ginsberg J; Geerts W; LeClerc J; Neemeh J; Powers P
Thromb Haemost; 1995 Aug; 74(2):606-11. PubMed ID: 8584992
[TBL] [Abstract][Full Text] [Related]
4. Deep-vein thrombosis and the incidence of subsequent symptomatic cancer.
Prandoni P; Lensing AW; Büller HR; Cogo A; Prins MH; Cattelan AM; Cuppini S; Noventa F; ten Cate JW
N Engl J Med; 1992 Oct; 327(16):1128-33. PubMed ID: 1528208
[TBL] [Abstract][Full Text] [Related]
5. Incidence, natural history and risk factors of deep vein thrombosis in elective knee arthroscopy.
Delis KT; Hunt N; Strachan RK; Nicolaides AN
Thromb Haemost; 2001 Sep; 86(3):817-21. PubMed ID: 11583313
[TBL] [Abstract][Full Text] [Related]
6. Risk of venous thromboembolism recurrence: high negative predictive value of D-dimer performed after oral anticoagulation is stopped.
Palareti G; Legnani C; Cosmi B; Guazzaloca G; Pancani C; Coccheri S
Thromb Haemost; 2002 Jan; 87(1):7-12. PubMed ID: 11848459
[TBL] [Abstract][Full Text] [Related]
7. Venous thrombosis in patients with solid tumors: determination of frequency and characteristics.
Sallah S; Wan JY; Nguyen NP
Thromb Haemost; 2002 Apr; 87(4):575-9. PubMed ID: 12008937
[TBL] [Abstract][Full Text] [Related]
8. Deep vein thrombosis in primary care: possible malignancy?
Oudega R; Moons KG; Karel Nieuwenhuis H; van Nierop FL; Hoes AW
Br J Gen Pract; 2006 Sep; 56(530):693-6. PubMed ID: 16954002
[TBL] [Abstract][Full Text] [Related]
9. Relation between the time to achieve the lower limit of the APTT therapeutic range and recurrent venous thromboembolism during heparin treatment for deep vein thrombosis.
Hull RD; Raskob GE; Brant RF; Pineo GF; Valentine KA
Arch Intern Med; 1997 Dec 8-22; 157(22):2562-8. PubMed ID: 9531224
[TBL] [Abstract][Full Text] [Related]
10. Predicting recurrences or major bleeding in cancer patients with venous thromboembolism. Findings from the RIETE Registry.
Trujillo-Santos J; Nieto JA; Tiberio G; Piccioli A; Di Micco P; Prandoni P; Monreal M;
Thromb Haemost; 2008 Sep; 100(3):435-9. PubMed ID: 18766259
[TBL] [Abstract][Full Text] [Related]
11. Oral anticoagulant therapy in venous thromboembolism.
Cosmi B; Palareti G
Semin Vasc Med; 2003 Aug; 3(3):303-14. PubMed ID: 15199464
[TBL] [Abstract][Full Text] [Related]
12. Low-molecular-weight heparin or oral anticoagulation for secondary prevention of deep vein thrombosis in cancer patients.
Levine M
Semin Thromb Hemost; 2003 Dec; 29 Suppl 1():9-11. PubMed ID: 14730472
[TBL] [Abstract][Full Text] [Related]
13. The predictive value of D-dimer measurement for cancer in patients with deep vein thrombosis.
Schutgens RE; Beckers MM; Haas FJ; Biesma DH
Haematologica; 2005 Feb; 90(2):214-9. PubMed ID: 15710574
[TBL] [Abstract][Full Text] [Related]
14. Long-term clinical follow-up in 265 patients with deep venous thrombosis initially treated with either unfractionated heparin or dalteparin: a retrospective analysis.
Holmström M; Aberg W; Lockner D; Paul C
Thromb Haemost; 1999 Oct; 82(4):1222-6. PubMed ID: 10544902
[TBL] [Abstract][Full Text] [Related]
15. Risk factors and recurrence rate of primary deep vein thrombosis of the upper extremities.
Martinelli I; Battaglioli T; Bucciarelli P; Passamonti SM; Mannucci PM
Circulation; 2004 Aug; 110(5):566-70. PubMed ID: 15262837
[TBL] [Abstract][Full Text] [Related]
16. Comparative study on risk factors and early outcome of symptomatic distal versus proximal deep vein thrombosis: results from the OPTIMEV study.
Galanaud JP; Sevestre-Pietri MA; Bosson JL; Laroche JP; Righini M; Brisot D; Boge G; van Kien AK; Gattolliat O; Bettarel-Binon C; Gris JC; Genty C; Quere I;
Thromb Haemost; 2009 Sep; 102(3):493-500. PubMed ID: 19718469
[TBL] [Abstract][Full Text] [Related]
17. Treatment of venous thromboembolism in patients with cancer: subgroup analysis of the Matisse clinical trials.
van Doormaal FF; Raskob GE; Davidson BL; Decousus H; Gallus A; Lensing AW; Piovella F; Prins MH; Büller HR
Thromb Haemost; 2009 Apr; 101(4):762-9. PubMed ID: 19350123
[TBL] [Abstract][Full Text] [Related]
18. A comparison of the safety and efficacy of oral anticoagulation for the treatment of venous thromboembolic disease in patients with or without malignancy.
Palareti G; Legnani C; Lee A; Manotti C; Hirsh J; D'Angelo A; Pengo V; Moia M; Coccheri S
Thromb Haemost; 2000 Nov; 84(5):805-10. PubMed ID: 11127860
[TBL] [Abstract][Full Text] [Related]
19. Thrombophilic abnormalities and recurrence of venous thromboembolism in patients treated with standardized anticoagulant treatment.
Santamaria MG; Agnelli G; Taliani MR; Prandoni P; Moia M; Bazzan M; Guazzaloca G; Ageno W; Bertoldi A; Silingardi M; Tomasi C; Ambrosio GB;
Thromb Res; 2005; 116(4):301-6. PubMed ID: 16038714
[TBL] [Abstract][Full Text] [Related]
20. Ovarian vein thrombosis: incidence of recurrent venous thromboembolism and survival.
Wysokinska EM; Hodge D; McBane RD
Thromb Haemost; 2006 Aug; 96(2):126-31. PubMed ID: 16894453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
